Your browser doesn't support javascript.
loading
Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.
Mouttet, D; Laé, M; Caly, M; Gentien, D; Carpentier, S; Peyro-Saint-Paul, H; Vincent-Salomon, A; Rouzier, R; Sigal-Zafrani, B; Sastre-Garau, X; Reyal, F.
Afiliación
  • Mouttet D; Department of Surgery, Institut Curie, Paris, France.
  • Laé M; Department of Tumor Biology, Institut Curie, Paris, France.
  • Caly M; Department of Tumor Biology, Institut Curie, Paris, France.
  • Gentien D; Department of Translational Research, Institut Curie, Paris, France.
  • Carpentier S; QIAGEN Marseille SA, Marseille, France.
  • Peyro-Saint-Paul H; QIAGEN Marseille SA, Marseille, France.
  • Vincent-Salomon A; Department of Tumor Biology, Institut Curie, Paris, France.
  • Rouzier R; Department of Surgery, Institut Curie, Paris, France.
  • Sigal-Zafrani B; Department of Tumor Biology, Institut Curie, Paris, France.
  • Sastre-Garau X; Department of Tumor Biology, Institut Curie, Paris, France.
  • Reyal F; Department of Surgery, Institut Curie, Paris, France.
PLoS One ; 11(2): e0146474, 2016.
Article en En | MEDLINE | ID: mdl-26829108

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Progesterona / Receptores de Estrógenos / Receptor ErbB-2 Tipo de estudio: Prognostic_studies Idioma: En Revista: PLoS One Año: 2016 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Progesterona / Receptores de Estrógenos / Receptor ErbB-2 Tipo de estudio: Prognostic_studies Idioma: En Revista: PLoS One Año: 2016 Tipo del documento: Article País de afiliación: Francia